Please use this identifier to cite or link to this item:
|Title:||Tailoring Biodiversity for Development of New Therapeutics|
|Abstract:||The nature remains as the potential source of organic structures of unparalleled diversity.Successful drug discovery process is often a function of the diversity of chemotypes examined, and therefore, drug discovery programs must aim to evaluate broadest diversity of chemical classes from natural resources in minimum samples and least time.|
|ISSN:||0975-1092 (Online); 0972-592X (Print)|
|Appears in Collections:||NPR Vol.1(3) [May-June 2002]|
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.